Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 18 results.
User Information
Export Records
  1. 1.   Genomic HIV RNA Induces Innate Immune Responses through RIG-I-Dependent Sensing of Secondary-Structured RNA
  2. Berg, R. K.; Melchjorsen, J.; Rintahaka, J.; Diget, E.; Soby, S.; Horan, K. A.; Gorelick, R. J.; Matikainen, S.; Larsen, C. S.; Ostergaard, L.; Paludan, S. R.; Mogensen, T. H.
  3. Plos One. 2012, Jan; 7(1):
  1. 2.   Comparison of immune responses generated by optimized DNA vaccination against SIV antigens in mice and macaques
  2. Kulkarni, V.; Jalah, R.; Ganneru, B.; Bergamaschi, C.; Alicea, C.; von Gegerfelt, A.; Patel, V.; Zhang, G. M.; Chowdhury, B.; Broderick, K. E.; Sardesai, N. Y.; Valentin, A.; Rosati, M.; Felber, B. K.; Pavlakis, G. N.
  3. Vaccine. 2011, Sep; 29(39): 6742-6754.
  1. 3.   HSV-2 Infection of Dendritic Cells Amplifies a Highly Susceptible HIV-1 Cell Target
  2. Martinelli, E.; Tharinger, H.; Frank, I.; Arthos, J.; Piatak, M.; Lifson, J. D.; Blanchard, J.; Gettie, A.; Robbiani, M.
  3. Plos Pathogens. 2011, Jun; 7(6): 14.
  1. 4.   Highly Efficient Method for C-5 Halogenation of Pyrimidine-Based Nucleosides in Ionic Liquids
  2. Kumar, V.; Yap, J.; Muroyama, A.; Malhotra, S. V.
  3. Synthesis-Stuttgart. 2009, Dec; (23): 3957-3962.
  1. 5.   The Nucleoside Analogue D-carba T Blocks HIV-1 Reverse Transcription
  2. Boyer, P. L.; Vu, B. C.; Ambrose, Z.; Julias, J. G.; Warnecke, S.; Liao, C. Z.; Meier, C.; Marquez, V. E.; Hughes, S. H.
  3. Journal of Medicinal Chemistry. 2009 52(17): 5356-5364.
  1. 6.   A Macaque Model to Study Vaginal HSV-2/Immunodeficiency Virus Co-Infection and the Impact of HSV-2 on Microbicide Efficacy
  2. Crostarosa, F.; Aravantinou, M.; Akpogheneta, O. J.; Jasny, E.; Shaw, A.; Kenney, J.; Piatak, M.; Lifson, J. D.; Teitelbaum, A.; Hu, L. Y.; Chudolij, A.; Zydowsky, T. M.; Blanchard, J.; Gettie, A.; Robbiani, M.
  3. Plos One. 2009 4(11):
  1. 7.   The nucleoside analogs 4 ' C-Methyl thymidine and 4 ' C-Ethyl thymidine block DNA synthesis by wild-type HIV-1 RT and excision proficient NRTI resistant RT variants
  2. Boyer, P. L.; Julias, J. G.; Ambrose, Z.; Siddiqui, M. A.; MarqueZ, V. E.; Hughes, S. H.
  3. Journal of Molecular Biology. 2007, Aug; 371(4): 873-882.
  1. 8.   Defensin participation in innate and adaptive immunity
  2. Yang, D.; Liu, Z. H.; Tewary, P.; Chen, Q.; De la Rosa, G.; Oppenheim, J. J.
  3. Current Pharmaceutical Design. 2007 13(30): 3131-3139.
  1. 9.   Critical design features of phenyl carboxylate-containing polymer microbicides
  2. Rando, R. F.; Obara, S.; Osterling, M. C.; Mankowski, M.; Miller, S. R.; Ferguson, M. L.; Krebs, F. C.; Wigdahl, B.; Labib, M.; Kokub, H.
  3. Antimicrobial Agents and Chemotherapy. 2006, Sep; 50(9): 3081-3089.
  1. 10.   Potent antiviral activity of North-methanocarbathymidine against Kaposi's sarcoma-associated herpesvirus
  2. Zhu, W. M.; Burnette, A.; Dorjsuren, D.; Roberts, P. E.; Huleihel, M.; Shoemaker, R. H.; Marquez, V. E.; Agbaria, R.; Sei, S.
  3. Antimicrobial Agents and Chemotherapy. 2005, DEC; 49(12): 4965-4973.
  1. 11.   Heparan sulfate Proteoglycans mediate attachment and entry of human T-cell leukemia virus type 1 virions into CD4(+) T cells
  2. Jones, K. S.; Petrow-Sadowski, C.; Bertolette, D. C.; Huang, Y.; Ruscetti, F. W.
  3. Journal of Virology. 2005, OCT; 79(20): 12692-12702.
  1. 12.   Dynamics of the antiviral activity of N-methanocarbathymidine against herpes simplex virus type 1 in cell culture
  2. Huleihel, M.; Talishanisky, M.; Ford, H.; Marquez, V. E.; Kelley, J. A.; Johns, D. G.; Agbaria, R.
  3. International Journal of Antimicrobial Agents. 2005, MAY; 25(5): 427-432.
  1. 13.   TRAF2 plays a key, nonredundant role in LIGHT-lymphotoxin beta receptor signaling
  2. Kim, Y. S.; Nedospasov, S. A.; Liu, Z. G.
  3. Molecular and Cellular Biology. 2005, MAR; 25(6): 2130-2137.
  1. 14.   Virally stimulated plasmacytoid dendritic cells produce chemokines and induce migration of T and NK cells
  2. Megjugorac, N. J.; Young, H. A.; Amrute, S. B.; Olshalsky, S. L.; Fitzgerald-Bocarsly, P.
  3. Journal of Leukocyte Biology. 2004 75(3): 504-514.
  1. 15.   Next generation DNA vaccines for HIV-1
  2. Boyer, J. D.; Chattergoon, M.; Muthumani, K.; Kudchodkar, S.; Kim, J.; Bagarazzi, M.; Pavlakis, G.; Sekaly, R.; Weiner, D. B.
  3. Journal of Liposome Research. 2002 12(1-2): 137-142.
  1. 16.   Issues for improving multiplasmid DNA vaccines for HIV-1
  2. Muthumani, K.; Kudchodkar, S.; Zhang, D. H.; Bagarazzi, M. L.; Kim, J. J.; Boyer, J. D.; Ayyavoo, V.; Pavlakis, G. N.; Weiner, D. B.
  3. Vaccine. 2002 20(15, Special Issue): 1999-2003.
  1. 17.   Biologically active proteins from natural product extracts
  2. O'Keefe, B. R.
  3. Journal of Natural Products. 2001 64(10): 1373-1381.
  1. 18.   Novel fold and capsid-binding properties of the lambda-phage display platform protein gpD
  2. Yang, F.; Forrer, P.; Dauter, Z.; Conway, J. F.; Cheng, N. Q.; Cerritelli, M. E.; Steven, A. C.; Pluckthun, A.; Wlodawer, A.
  3. Nature Structural Biology. 2000 7(3): 230-237.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel